Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Oncology|December 1, 1982
PALA in advanced breast cancer. A phase II pilot study by the ECOGS G Taylor, T E Davis, G Falkson, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery|June 5, 2001
Does contraction of mesh following tension free hernioplasty effect testicular or femoral vessel blood flow?S G Taylor, A Hair, G M Baxter, et al.
Archives of Otolaryngology (Chicago, Ill. : 1960)|August 1, 1983
A randomized trial of adjuvant BCG immunotherapy in head and neck cancerS G Taylor, G A Sisson, D E Bytell, et al.
Journal of the National Cancer Institute|April 1, 1982
TG cell involvement in the leukocyte adherence inhibition phenomenonS G Taylor, P C Saffold, D P Braun, et al.
Journal of Biological Response Modifiers|June 1, 1987
Modification of the effects of cytotoxic chemotherapy on the immune responses of cancer patients with a nonsteroidal, antiinflammatory drug, piroxicam. A pilot study of the Eastern Cooperative Oncology GroupD P Braun, P D Bonomi, S G Taylor, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1993
Phase II evaluation of Taxol in advanced head and neck cancer: an Eastern Cooperative Oncology group trialA A Forastiere, D Neuberg, S G Taylor, et al.
British Journal of Pharmacology|July 1, 1988
Endothelium-dependent effects of acetylcholine in rat aorta: a comparison with sodium nitroprusside and cromakalimS G Taylor, J S Southerton, A H Weston, et al.
Medical and Pediatric Oncology|January 1, 1979
Bleomycin in combination chemotherapy of metastatic Wilms tumor: a late recurrent case, refractory to conventional therapyT Kisielius, A Bianco, J M Merrill, et al.
Cancer Treatment Reports|June 1, 1984
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancerE C Cadman, J H Glick, J Cross, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patientsK W Gilchrist, R Gray, B Fowble, et al.
Pageof 11